| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 08/27/2002 | US6441021 Type-iv collagenase inhibitors |
| 08/27/2002 | US6441015 Tetrazole compounds as thyroid receptor ligands |
| 08/27/2002 | US6440956 Bicyclic polyaminoacid metal complexes, their process of preparation and their application in medical imaging |
| 08/22/2002 | WO2002064559A2 Thrombin inhibitors |
| 08/22/2002 | WO2002064136A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/22/2002 | WO2002064094A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/22/2002 | WO2002063957A2 Selective substituted aryl ketone and safener based herbicides |
| 08/22/2002 | WO2002013875A3 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 08/22/2002 | WO2002004412A3 Tyrosine derivatives as phosphatase inhibitors |
| 08/22/2002 | US20020115653 Retinoic acid mimetic anilides |
| 08/22/2002 | US20020114770 For skin lightening or depigmentation; works by inhibiting tyrosinase in humans; kits |
| 08/22/2002 | CA2437760A1 Selective substituted aryl ketone and safener based herbicides |
| 08/22/2002 | CA2437118A1 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/22/2002 | CA2436176A1 Thrombin inhibitors |
| 08/20/2002 | US6437177 α-hydroxy, -amino, and halo derivatives of β-sulfonyl hydroxamic acids as matrix metallopropteinases inhibitors |
| 08/15/2002 | WO2002062810A2 Linkable sialyl lewis x analogs |
| 08/15/2002 | WO2002030860A3 Ketone compounds and compositions for cholesterol management and related uses |
| 08/14/2002 | EP1229907A1 Prevention of plaque rupture by acat inhibitors |
| 08/14/2002 | EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors |
| 08/14/2002 | EP0708761B1 Enhanced relaxivity monomeric and multimeric compounds |
| 08/14/2002 | DE10106420A1 Selektive Herbizide auf Basis von substituierten Arylketonen und Safenern Selective herbicides based on substituted aryl ketones and safeners |
| 08/14/2002 | CN1364156A Novel naphthalene ureas as glucose uptake enhancers |
| 08/13/2002 | US6433181 Adding ammonia water to a reaction solution containing a 5,5'-bi-1h-tetrazoledisodium salt; recovering pure 5,5'-bi-1h- tetrazolediammonium salt |
| 08/07/2002 | EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 08/07/2002 | EP1228029A1 Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| 08/07/2002 | CN1362951A Dihetero-substituted metalloprotease inhibitors |
| 08/07/2002 | CN1362640A Silver-halides photo-sensitive emulsion layer with reinforced photographic photosensibility |
| 08/07/2002 | CN1088709C Amine compound and its acid addition salt |
| 08/01/2002 | WO2002059122A1 ANTI-CANCER 2,3-DIHYDRO-1H-PYRROLO[3,2-f]QUINOLINE COMPLEXES OF COBALT AND CHROMIUM |
| 08/01/2002 | WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 08/01/2002 | WO2002058636A2 Novel cannabimimetic ligands |
| 08/01/2002 | WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 08/01/2002 | US20020103205 Muscarinic antagonists |
| 08/01/2002 | US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone |
| 08/01/2002 | DE10104389A1 Multimere Photosensibilisatoren sowie deren Konjugate für die PDT Multimers photosensitizers and their conjugates for PDT |
| 08/01/2002 | CA2435653A1 Anti-cancer 2,3-dihydro-1h-pyrrolo[3,2-f]quinoline complexes of cobalt and chromium |
| 08/01/2002 | CA2435409A1 Novel cannabimimetic ligands |
| 07/31/2002 | EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 07/30/2002 | US6426349 Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia |
| 07/30/2002 | US6426059 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 07/25/2002 | US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 07/25/2002 | US20020098152 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents |
| 07/24/2002 | EP0836485B1 Cascade polymer complexes |
| 07/24/2002 | EP0684945B1 Pyrazole- or isoxazole-substituted alkyl amide acat inhibitors |
| 07/24/2002 | CN1360570A Phenyl sulfamate derivs. |
| 07/23/2002 | US6423729 Therapeutic or prophylactic agent for glomerulopathy |
| 07/18/2002 | WO2002012224A3 Bicyclic compounds as h3 receptor ligands |
| 07/17/2002 | EP1223166A1 Linked cyclic polyamines with activity against hiv. |
| 07/17/2002 | EP0980360B1 A process for the preparation of 1,4,7,10-tetraazacyclododecane |
| 07/16/2002 | US6420341 Treating vasoconstrictor and hypertension effects in warm-blooded animals |
| 07/16/2002 | CA2059704C [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives |
| 07/11/2002 | US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 07/11/2002 | DE10064467A1 Lithium-Komplexe von N-(1-Hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecan, deren Herstellung und Verwendung Lithium complexes of N- (1-hydroxymethyl-2,3-dihydroxypropyl) -1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, their production and use |
| 07/10/2002 | EP1220836A2 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 07/10/2002 | EP1220832A1 Novel aromatic compounds |
| 07/10/2002 | EP1220831A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 07/10/2002 | CN1358095A Method for treating chronic pain uisng MEK inhibitors |
| 07/10/2002 | CN1087283C New LH-RH antigonists with improved effectiveness |
| 07/09/2002 | US6417354 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid |
| 07/09/2002 | US6417178 Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits |
| 07/09/2002 | US6416601 Mineral acid other than nitric acid (hydrchloric acid) increases the rate of aluminum digestion without use of solvent; useful in solid rocket motor propellants, explosives, and pyrotechnics |
| 07/04/2002 | WO2002051799A1 Biphenyl derivatives |
| 07/04/2002 | WO2002022627A3 Ligands for metabotropic glutamate receptors |
| 07/03/2002 | EP1220024A2 Silver halide photographic element |
| 07/03/2002 | EP0983235B1 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists |
| 07/03/2002 | EP0983234B1 Leukotriene b 4 derivatives, in particular 7-methylcyclohexyl-ltb 4 antagonists |
| 07/03/2002 | EP0973776B1 A process for the preparation of tetraazamacrocycles |
| 07/03/2002 | CN1356977A Glucagon antagonists/inverse agonists |
| 07/02/2002 | US6413996 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 07/02/2002 | CA2038493C 1,4,7,10-tetraazacyclododecane butyltriols |
| 07/02/2002 | CA2006372C Process for preparing isothiocyanato functionalized metal complexes |
| 07/02/2002 | CA1341373C Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates |
| 06/27/2002 | US20020082283 Increasing the function of the N-methylaspartic acid (NMDA) receptor without the inherent side-effects associated with modulation of the glutamate binding site |
| 06/27/2002 | US20020082265 For treating or preventing emphysema, cancer and dermatological disorders |
| 06/26/2002 | EP0908453B1 Water-soluble tetrazolium salt compounds |
| 06/25/2002 | US6410780 C11 oxymyl and hydroxylamino prostaglandins useful as medicaments |
| 06/25/2002 | US6410736 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 06/25/2002 | US6410585 Therapy for non-insulin depend diabetes |
| 06/25/2002 | US6410542 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| 06/20/2002 | WO2002048119A2 Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof |
| 06/20/2002 | WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 06/20/2002 | US20020077342 For use in therapy of epilepsy, depression, tension, gastrointestinal disorders, pain, inflammation |
| 06/20/2002 | US20020077339 Chemokine receptor binding heterocyclic compounds |
| 06/20/2002 | US20020077316 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; Alzheimer's Disease; Syndrome X; peroxisome proliferator activated receptor-associated disorder |
| 06/20/2002 | US20020076380 Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use |
| 06/19/2002 | CN1354751A Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging |
| 06/18/2002 | US6407253 Method for preparing 4-methyl-biphenyl derivatives |
| 06/13/2002 | WO2002046129A2 Inhibitors of histone deacetylase |
| 06/13/2002 | WO2002045750A1 Combination drugs |
| 06/13/2002 | WO2002013874A8 Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses |
| 06/13/2002 | WO1999059957A9 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 06/12/2002 | EP0815091B1 Polyazacycloalkane compounds |
| 06/12/2002 | CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds |
| 06/11/2002 | US6403620 Inhibitors of factor Xa with a neutral P1 specificity group |
| 06/11/2002 | US6403600 Fungicides. |
| 06/06/2002 | WO2002020474A3 Resorcinol derivatives |
| 06/05/2002 | EP1210339A1 Benzoic acid derivatives for the treatment of diabetes mellitus |
| 06/05/2002 | EP0670832B1 Hepatobiliary magnetic resonance contrast agents |
| 06/04/2002 | US6399641 For therapy and prophylaxis of psychosis, schizophrenia, alzheimer's disease, cognitive disorders and restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries etc. |
| 06/04/2002 | US6399627 Anticoagulants; prothrominase, serine protease inhibitor; acrylamide derivatives |